Mahana Therapeutics, a developer of prescription digital therapeutics, has secured $61 million in Series B financing. JAZZ Venture Partners and Gurnet Point Capital led the round with significant participation from Main Street Advisors, KKCG and Lux Capital.
Source: Press Release
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: